Red blood cells play a crucial role in the local regulation of oxygen supply in the microcirculation through the oxygen dependent release of ATP. Since red blood cells serve as an oxygen sensor for the circulatory system, the dynamics of ATP release determine the effectiveness of red blood cells to relate the oxygen levels to the vessels. Previous work has focused on the feasibility of developing a microfluidic system to measure the dynamics of ATP release. The objective was to determine if a steep oxygen gradient could be developed in the channel to cause a rapid decrease in hemoglobin oxygen saturation in order to measure the corresponding levels of ATP released from the red blood cells. In the present study, oxygen transport simulations were used to optimize the geometric design parameters for a similar system which is easier to fabricate. The system is composed of a microfluidic device stacked on top of a large, gas impermeable flow channel with a hole to allow gas exchange. The microfluidic device is fabricated using soft lithography in polydimethyl-siloxane, an oxygen permeable material. Our objective is twofold: (1) optimize the parameters of our system and (2) develop a method to assess the oxygen distribution in complex 3D microfluidic device geometries. 3D simulations of oxygen transport were performed to simulate oxygen distribution throughout the device. The simulations demonstrate that microfluidic device geometry plays a critical role in molecule exchange, for instance, changing the orientation of the short wide microfluidic channel results in a 97.17% increase in oxygen exchange. Since microfluidic devices have become a more prominent tool in biological studies, understanding the transport of oxygen and other biological molecules in microfluidic devices is critical for maintaining a physiologically relevant environment. We have also demonstrated a method to assess oxygen levels in geometrically complex microfluidic devices.
Citation: Sové RJ, Fraser GM, Goldman D, Ellis CG (2016) Finite Element Model of Oxygen Transport for the Design of Geometrically Complex Microfluidic Devices Used in Biological Studies. PLoS ONE 11(11): e0166289. https://doi.org/10.1371/journal.pone.0166289
Editor: Keng-Hwee Chiam, Bioinformatics Institute, SINGAPORE
Received: June 24, 2016; Accepted: October 26, 2016; Published: November 9, 2016
Copyright: © 2016 Sové et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Data Availability: All relevant data are within the paper.
Funding: This research is funded by the Natural Sciences and Engineering Research Council of Canada (R1379A13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: The authors have declared that no competing interests exist.
Red blood cells (RBCs) have been shown to release adenosine triphosphate (ATP) in response to numerous stimuli [1–4], including hemoglobin oxygen saturation (SO2) . Following release, ATP binds to purinergic receptors on capillary endothelial cells which conduct an electrical response to upstream arterioles, leading to their vasodilation . Therefore, RBCs are believed to play an important role in the local regulation of oxygen (O2) distribution through the SO2 dependent release of ATP [7, 8].
In addition to its importance in regulatory physiology, SO2 dependent ATP release has been shown to be impaired in many cardiovascular diseases such as sepsis , prediabetes  and type II diabetes . In these studies, the amount of ATP released was decreased for the same stimulus. Therefore, RBCs become a potential screening target for cardiovascular disorders.
Although SO2 dependent ATP release has been measured, there are currently no studies that quantify the dynamics of this process. Since ATP release is believed to be involved in the regulation of O2 distribution, understanding the dynamics is crucial for our understanding of the regulatory pathway. The time required for ATP to be released determines the spatial sensitivity for the RBC to signal the endothelium changes in their SO2.
The ultimate goal of our research is to develop a cost effective tool to quantify the dynamics of ATP release from RBCs furthering our ability to characterize the underlying physiology of blood flow regulation. Various studies in the literature have developed means of controlling O2 in microfluidic devices for a variety of applications [12–19], e.g. microfluidic devices for establishing hypoxia in cell cultures . Many of these studies apply mathematical modelling to verify that they are correctly maintaining their target O2 levels [13–15, 17, 18].
In an earlier study, we employed a novel micro-delivery approach to change local oxygen levels in vivo [20, 21]. We also previously described a computational model of an idealized microfluidic device to measure the dynamics of SO2 dependent ATP release in vitro . The objective of the design was to create a spatial step change in SO2 in a steady flowing channel, then measure the corresponding ATP released from the RBCs. The resulting spatial information can then be translated into temporal. This approach was adapted from Wan et al , and is described in detail in our previous study . In contrast to other devices for controlling oxygen, our application is intended to spatially control the O2 content of flowing RBCs.
Although the previous model predicted that the device was able to create a sufficient drop in O2, the idealized microfluidic device was not practical to fabricate using common soft lithography techniques. This motivated a new device design that is both practical and functional. However, the complex geometric design of the new device and the use of O2 permeable materials makes predicting the SO2 of the RBCs more difficult. Therefore, in this study we develop a 3D computational model of the new device, in order to optimize the dimensions, and to ensure that O2 characteristics in the device are sufficient for quantifying the dynamics of SO2 dependent ATP release. Additionally, this model will be crucial to aid in the analysis of results of subsequent studies using this design.
In this work, we take a computational approach to design a device for measuring the dynamics of SO2 dependent ATP release from RBCs. We propose a device that consists of two parts (see Fig 1), the first part being a microfluidic channel fabricated in PDMS using soft lithography techniques. This channel will be embedded in PDMS using a mould, and sealed with a PDMS spin coating technique. The second part being a large oxygen impermeable gas flow channel with a window to allow gas exchange between the two channels. The two parts are aligned orthogonal to each other with the gas exchange window centred at their intersection. The bottom channel is designed to deliver a gas with a low concentration of oxygen, whereas the top microfluidic channel will deliver fully oxygen-saturated red blood cells suspended in a physiological buffer. The large gradient in oxygen partial pressure at the exchange window between the two channels drives the desaturation of the RBCs.
Diagram of x-normal (left) and z-normal (right) views of the RBC channel and exchange window. The light blue colour represents PDMS and the grey colour represents glass.
In the present work, we will explore the influence of geometry on the device’s ability to control the oxygen levels the cells are exposed to using a computational model of fluid dynamics and mass transfer (kinetics of ATP release and reaction with luciferin/luciferase will be simulated in a subsequent model); see Fig 1 for the geometry. Due to the large number of geometric parameters we can vary, we start by analyzing a 1D analytic model of oxygen exchange to guide our choice of parameters to vary with the 3D model.
The following equation describes the oxygen partial pressure, PO2, of the blood in a microfluidic device with an exchange window of length Lw centred at x = 0. (1) with boundary conditions, (2a) (2b) where D is diffusivity of oxygen in plasma, c is the flow velocity, and k1 and k2 are the rates of oxygen permeation through the walls of the channel and the exchange window respectively; they depend on the thickness of the PDMS walls and the permeability of PDMS to O2. P0 is the external oxygen partial pressure and Pl is the oxygen partial pressure of the gas in the exchange window. The microfluidic device is assumed to be infinitely long so that we can neglect inlet/outlet effects and the effects of oxygen binding to hemoglobin are neglected in the model.
Non-dimensionalization allows us to determine the parameters that effect the behaviour of the solution. We introduce the following dimensionless parameters: , , u = 1 − v, , and which gives, (3) with homogeneous boundary conditions at infinity. Dimensionless O2 is represented by v and the dimensionless drop in O2 is represented by u. From the non-dimensionalization, we see that the behaviour of the solution depends on three independent parameters, Pe, S1 and S2. Pe is the Peclet number and represents the ratio of convective to diffusive transport. S1 and S2 are dimensionless k1 and k2, respectively. The dimensionless solution for a specific case is shown in Fig 2.
Solution to the 1D dimensionless model. The dimensionless O2, v, is shown as a function of dimensionless position, ξ for Pe = 10, S1 = 5 and S2 = 20. The exchange window is between 0 and 1. The red arrow indicates Δξ = 1.04 with umax of 0.68. For this set of conditions, dimensionless O2 begins to fall just before the window and continues to fall across the length of the window before beginning to rise.
There are three main criteria that we will use to assess the performance of the device. First, the device must be able to cause a large enough change in O2 to elicit ATP release from the RBCs. This first criterion can be quantified by taking the maximum drop in PO2. Eq 4 gives this criterion in terms of the 1D model parameters, (4) where umax is the maximum value of u(ξ).
Second, the drop in O2 must be sufficiently rapid to resolve the dynamics of ATP release. This can be quantified as the amount of time between the maximum and the minimum PO2. Since this time depends on ΔPO2max, we normalize it with respect the drop. This criterion is a representation of the rate of O2 drop. Eq 5 gives the second criterion in terms of the 1D model parameters, (5) where Δξ is the change in dimensionless position between when the maximum and minimum value of u(ξ) deviate by 1% of their original values.
Third, the temporal resolution of the system has to be able to resolve the dynamics. This can be quantified in terms of the spatial resolution, ϵ, of the system and the flow velocity, c, as .
To select the ideal parameters for the 1D model, we optimize our three performance criteria. The parameters involved are the physical parameters (P0 − Pl), c, and L and the dimensionless parameters umax and Δξ, which are dependent on Pe, S1 and S2. In order to maximize the maximum drop in PO2, umax has to be maximized. Fig 3 shows umax as a function of Pe for different values of S1 and S2. From Fig 3, umax is maximized as Pe → 0, S1 → 0 and S2 → ∞. As S2 increases, umax becomes less sensitive to S1 and Pe.
The maximum dimensionless O2 drop, umax, as a function of Péclet number, Pe. The solid, dashed and dot-dashed curves represent S1 values of 1, 5 and 10, respectively. The red, black and blue curves represent values of S2 of 5, 20 and 80 respectively.
In order to maximize the rate of O2 drop, umax/Δξ should be maximized. Fig 4 shows umax/Δξ as a function of Pe for varying values of S1 and S2. From Fig 4, umax/Δξ is maximized for large Pe, small S1, and large S2. The effect of S2 on O2 drop rate is larger than that of S1.
The dimensionless rate of O2, umax/Δξ, as a function of the Péclet number, Pe. The solid, dashed and dot-dashed curves represent S1 values of 1, 5 and 10, respectively. The red, black and blue curves represent values of S2 of 5, 20 and 80 respectively.
To optimize both umax and umax/Δξ a compromise in Pe must be chosen since umax is maximized for small Pe and umax/Δξ is maximized for large Pe. However, since the effects of Pe on umax are small for large S2, if we can choose large S2, we can choose the Pe to satisfy the optimization of umax/Δξ.
Since we cannot control diffusivity, the dimensionless parameters must be controlled by altering c, L, k1 and k2. To minimize S1, k1 should be as small as practical; physically this can be achieved by making the walls as thick as possible. To maximize S2, k2 should be made as large as possible; this can be achieved by making the spin coat layer as small as possible. (P0 − Pl) should also be made as large as practical.
The flow velocity, c, affects Pe, ΔPO2max/Δt and the temporal resolution, τ. All three parameters are optimized with a larger c. The effect of window length, Lw, is less straightforward since it effects the dimensionless parameters and ΔPO2max/Δt. S1 and S2 are sensitive to Lw since they are related quadratically, and since they have opposite optima, care must be taken while choosing the length of the exchange window. The effect of the window length will be explored with the 3D model.
The geometry construction and mesh generation were performed using the open source software GMSH . The same mesh was used for both the fluid dynamics simulations and the mass transfer simulations.
For each geometry, a hybrid mesh was used, with structured regions in the flow channels and an unstructured region in the PDMS area (which is far from the region of interest) to reduce the number of elements. Element sizes were decreased until the solution no longer changed with mesh resolution. The resulting meshes varied between simulations, but typically the smallest elements (located in the RBC channel) were on the order of 0.01 mm, and the largest elements (located in the PDMS) were 0.5–1.0 mm.
Fluid Dynamics Simulations.
The flow in both channels were assumed to be Newtonian, incompressible and isothermal. The blood was assumed to be a single homogeneous fluid. The resulting steady-state equations for flow in both channels are given by: (6a) (6b) where , ρi, μi are the velocity, density and dynamic viscosity of the fluid respectively and p is the hydrodynamic pressure in the fluid. The subscripts i = g, p, rbc refer to the gas, plasma and red blood cells. Since the blood is assumed to be homogeneous , ρp = ρrbc and μp = μrbc.
Eqs 6a and 6b were solved numerically using open source software OpenFOAM . The software discretizes the equations using a finite volume method and solves the coupled system of equations using the Semi-Implicit Method for Pressure Linked Equations .
Mass Transfer Simulations.
The following equations were used to model the oxygen transport throughout the microfluidic device : (7a) (7b) (7c) where Di, ki, PO2, Ht, and [HbT] are the diffusivity, solubility, oxygen partial pressure, hematocrit and total heme concentration of the blood respectively. The different regions of the device are designated by Ωj, where the subscripts j = pdms, g, rbc, p represent the PDMS, gas, red blood cells and plasma respectively. The derivative can be found from the Hill equation : (8) where SO2 is hemoglobin oxygen saturation, N is the Hill coefficient and P50 is the partial pressure of oxygen at 50% saturation.
Eqs 7a–7c were discretized using in-house software that utilizes a stabilized Galerkin finite element method programmed in C++; a least squares stabilizer was used in the convective regions of the domain . The resulting non-linear system of equations were iteratively linearized and solved with the Generalized Minimal Residual Method . Convergence was verified for the extreme cases by refining the mesh to be sure that the solution was independent of the choice of discretization. All simulations were run on a personal computer with an 8 core 4.2 GHz processor with 16 GB of RAM. Simulation times were less than an hour on one core.
To quantify the O2 exchange in the 3D model we define the weighted drop in PO2 by the following, (9) where Wr and Hr are the width and height of the RBC channel, respectively, y0 is the location of the bottom of the channel and μ is the optical attenuation of blood plasma. This is a weighted integral of the PO2 along the depth of the channel (y-direction) to give a stronger weighting to the PO2 values closer to the bottom of the channel since that is where the detector will be located. It is then averaged across the width of the channel (z-direction) and the maximum value is taken along the stream-wise direction (x-direction).
The spatial drop time is quantified in the same way as for the 1D model; the 3D profile is reduced to one dimension by using the same weighted integral in y and taking the centreline in z.
To investigate the effects of 3D geometric features, we simulated the O2 transport in the microfluidic device for various dimensions of the RBC channel. In particular, we varied cross-sectional area of the RBC channel, as well as its aspect ratio to capture the effects of channel cross-section. In addition, we varied the length of the exchange window to determine how the O2 drop and its rate are affected. We also varied spin-coat thickness to determine how important it is for our particular geometry and physical conditions. Fig 5 shows a specific solution of the 3D model using the parameters in Table 1; this figure shows the weighted centreline profile.
The top left colormap shows the y-normal plane close to the bottom edge of the channel (y = 0.5775). The bottom left colormap shows the z-normal plane through the center of the geometry. The colormap on the top right shows the x-normal plane through the center of the geometry. The white dashed line indicates the RBC channel. The plot in the bottom right shows the weighted centreline drop in PO2. The black dashed line indicates the location of the exchange window.
First, the cross-sectional area of the RBC channel was varied maintaining a constant mean velocity. The channels simulated were square in cross-section ranging from 100x100 μm2 to 500x500 μm2. The maximum drop in PO2 increased with increasing cross-sectional area (see Fig 6). This appears to be due to the increased surface area for exchange as well as the increased volume in the channel contributing to the weighted drop. In contrast, rate of drop decreases with area. This is likely due to the increasing volume of the RBC channel.
The weighted O2 drop (blue) and weighted O2 drop rate (red) as a function of RBC channel cross-sectional Area. The channels simulated are square in cross-section.
From Fig 7, channels will smaller height to width ratio perform better at dropping the O2 compared to short, wide channels of the same area. This is due to multiple factors: first, the channels that are taller have more volume contributing to the weighted drop (see Eq 9). Second, the taller channels are thin, allowing the more surface area on their sides to be exposed to low O2. Fig 8 shows colour maps for the two extreme cases. The change in drop rate follows the same trend as with the weighted drop.
The weighted O2 drop (blue) and weighted O2 drop rate (red) as a function of RBC channel aspect ratio (width:height). The area of the channels simulated was held constant (0.15 mm2).
The PO2 solution showing the x-normal plane through the center of the geometry for two different aspect ratios. The colormap on the top shows the simulation results for a channel with 1:5 width to height ratio. The colormap on the bottom shows the simulation results for a channel with a 5:1 width to height ratio. The white dashed line indicates the RBC channel.
Increasing the length of the window causes an increased drop in PO2 and an increased drop rate (see Fig 9). The increase in PO2 drop can be explained by having a longer window, exposing more of the channel to low O2.
The weighted O2 drop (blue) and weighted O2 drop rate (red) as a function of exchange window length.
Increasing the spin-coat layer thickness causes a decrease in the drop in PO2; this relationship is approximately linear. The change in drop rate follows a similar trend to the drop in O2 (see Fig 10). In terms of the 1D model, increasing the spin-coat thickness increases S2, which causes a smaller drop in O2 and a smaller drop rate (see Figs 3 and 4); this trend agrees with our 3D results. Hematocrit has negligible effect on both the weighted drop and the drop rate (Fig 11).
The weighted O2 drop (blue) and weighted O2 drop rate (red) as a function of PDMS spin-coat thickness.
Ellsworth et al suggested that ATP release time is less than 500 milliseconds  based on the RBC transit time in an isolated arteriole preparation exposed to low oxygen levels. Based on this estimate, we require a system with a resolution on the order of milliseconds. Wan et al measured shear dependent ATP release time and reports it to be on the order of 25–75 milliseconds . If the mechanisms responsible for ATP release are similar for both shear-dependent and O2 dependent release, then we expect, ATP release time to be similar to the value measured in their study. Understanding the time course for ATP release from RBCs is important since it determines where in the vasculature ATP is released and where the vessels will sense ATP. Further, many inflammatory diseases have been associated with impaired ATP release, thus a measurement of ATP release dynamics could be used to screen for these diseases. ATP believed to be responsible for local control of oxygen, if release time is delayed, then this will impair ability to locally control oxygen; could become potential pharmaceutical target.
In previous work, we showed the feasibility of using steady-state flow to measure the dynamics of SO2-dependent ATP release in vitro . This work was based on an ideal device in order to test the viability of the concept. We demonstrated two important design criteria, first, that the device was able to cause a sufficient drop in O2 and second, that we were able to recover time-dependent changes in the ATP signal. Although this study was able to show the feasibility of our device, the idealized design described in this article was not practical to fabricate.
With the practical considerations in mind, we developed a simple 1D model of oxygen transport in our device in order to qualitatively evaluate some of the simulation parameters to reduce the number of simulations required to determine the optimal design for our application. The 1D model is an idealization of the device and does not account for geometric information such as the RBC channel’s cross-section dimensions, though some of the geometric information is embedded in the model parameters, such as PDMS thickness. To compare the performance of the 1D model against our 3D simulations, we show the weighted O2 drop predicted by the 1D model for varying exchange window lengths and PDMS spin coat thicknesses (see Fig 12).
Weighted O2 drop was simulated using the 1D model to determine the effect of varying exchange window length (left) and PDMS spin-coat thickness (right). The inset in the right panel shows the parameter range used in the 3D simulations. The results of the simulations were re-dimensionlized in order to be comparable to the 3D simulation results (see Figs 9 and 10). Note: the parameters range used in the 3D simulations for the exchange window length was 0.1–1.
The 1D model predicts the O2 drop to level off and reach a steady value as the exchange window length increases. The 3D model predicts the O2 drop to increase with increasing window length, though for the parameters used, the simulation results do not reach a steady drop. Further, the value of the drop is considerably lower then predicted by the 1D model. Considering the PDMS spin coat thickness, the 1D model predicts the O2 drop to approach zero as the thickness increases; the O2 drop is predicted to approach the maximum drop as the thickness approaches zero. Comparing these results to the 3D simulations, the O2 drop is substantially lower than predicted by the 1D model and does not begin to level off for the lowest thickness simulated. While the 1D model predictions appear reasonable, the O2 drop is overestimated compared to the 3D model and is more sensitive to the variations in the geometric parameters.
The 1D model approaches the 3D model as the RBC channel becomes infinitely wide and its height becomes infinitesimally small. It assumes cross-stream diffusion in the RBC flow is negligible and diffusion in the PDMS occurs only vertically. Further, the 1D model also assumes that the fluid velocity in the gas channel is infinite, so that the low oxygen is maintained at the gas channel side of the exchange surface. Due to these simplifications, the 1D model overestimates the drop in O2; these simplifications also account for the increased sensitivity of the geometric parameters. Although the 1D model does not accurately account for the O2 content in the device, it allows us to qualitatively determine the behaviour of changing certain parameters. Also, since the model can be solved analytically, we can simulate a large range and achieve practically continuous information. Therefore, the 1D analytical model is a useful tool for qualitatively understanding the physical details of our system, but a 3D model is required to quantify the extent of the behaviour.
Though the 1D model was useful in helping us determine how the O2 permeable walls will affect the O2 exchange, it fails to capture some of the important 3D features. Thus, we used a 3D model to explore how the O2 exchange is affected when we have a channel of finite cross-section and diffusion around the sides of the RBC channel from the exchange window and outside surfaces.
The first 3D aspect of the device geometry we look at is the RBC channel’s cross-section. From Fig 6, it is clear that there is an optimal cross-sectional area. Channels with larger cross-sectional areas have larger surface areas, leading to more area for the exchange. However, the exchange is limited to the lower walls of the channel since the exchange window is on the bottom. For the larger channels, the width of the window limits how much of the side walls’ surface area is exposed to the low levels of O2. If we now allow the channel to increase in surface area, but not get any wider, we can optimize the amount of surface area exposed to the low levels of oxygen; this is demonstrated in Figs 7 and 8. In contrast our previous results showed channels that are less deep are more beneficial since the drop extends across the whole channel . However, this was because the 2D model in  assumes that the channel and window are infinitely wide; thus, it neglects the effect of low oxygen on the sides of the channel.
In the 1D model, the length of the window is the characteristic length. Thus it not only effects O2 exchange through Eq 5, but it also effects umax and umax/Δξ through the dimensionless parameters. From Fig 9, we see that having a longer window is better for both the drop and the drop rate of O2. The benefits of longer windows will become less important as O2 in the channel approaches zero. Practically, a very large exchange window will result in a structurally weak device; the thin PDMS layer separating the RBC and gas channel may rupture or deform. Therefore, the exchange window should be large enough to cause a sufficient drop in oxygen, but not so long that the device becomes structurally compromised.
The 1D model indicates that the ideal device would have an infinitely thin spin-coat layer. However, practically, we need a barrier that closes the RBC channel so that it does not leak; thus it has to be thick enough so that it does not rupture under the pressure of the flow. Physically, we can fabricate spin-coat thicknesses on the order of 20 μm and these channels do not rupture under the pressure of the flow. From Fig 10, we can see that in the range of practical spin-coat sizes (20–100 μm), the spin-coat thickness does not affect the O2 exchange substantially. Therefore, small variability in the thickness of the spin coat layer will not affect the effectiveness of the device.
Interestingly, hematocrit has only a small effect on the O2 exchange in our device. From Fig 11, we can see that lower hematocrit is better for exchange, though, the change is not large. An important point to consider is that larger hematocrit will result in more RBCs available to release ATP, increasing the amount of signal coming form the system. However, the amount of RBCs affects the optics of the system since they absorb visible light. Therefore, we should use a hematocrit that is large enough to attain a measurable ATP signal, but not so large that all the signal is attenuated by the cells. We considered this effect in a previous study .
In this study, we did not simulate every possible geometric parameter, such as the length of the RBC channel, the height of the PDMS around the channel, the width of the window, and the dimensions of the gas channel. We no not expect the length of the RBC channel to be too important for exchange. For the purposes of the analysis of the experimental results, the flow should be fully developed. Therefore the channel should be longer than the entrance length, though at the flow rates typically used in microfluidics, the entrance lengths are quite small (on the order of 3–30 μm). As for oxygen exchange in shorter channels, the drop will be smaller since the source of oxygen is closer to the exchange window. This will also result in a steeper rate. However, these effects are only important for channels on the order of the entrance length.
Practically, the exchange window cannot exceed a width of 1 mm due to the risk of the PDMS spin-coat deforming into the window causing distortion to the optical image. Intuitively, wider windows will improve exchange since there will be more area for exchange, though the effect will become insignificant as the window becomes much wider than the channel. From the 1D model, we expect more PDMS around the RBC channel to be better as this decreases the effective permeability of the walls. However, if there is too much PDMS above the channel, there may be optical problems.
This study focuses on the ability of the proposed microfluidic device to cause a drop of PO2 in a flowing RBC suspension. However, the main goal of this device is to measure the release of ATP from RBCs in response to their SO2. The relationship between PO2 and SO2 is modelled by the Hill equations (Eq 8). Fig 13 shows the Hill equation for human RBCs. This figure demonstrates that for low and high PO2, large changes in PO2 are required to change saturation. In contrast, in the mid-range of PO2, only small changes in PO2 are required to produce large changes in SO2. Since the RBCs in our simulation span PO2 values from zero to 160, we expect our device to almost fully desaturate the RBCs.
Hemoglobin oxygen saturation as a function of partial pressure determined by the Hill equation.
The ideal device should have a low width to height ratio with a large area such that the width of the channel is much less than that of the exchange window. The device should have a spin-coat layer that is thin as possible, while still being able to withstand the flow pressure The exchange window should be long enough, but not so long that though it that the spin-coat layer sinks into the window. The hematocrit should be chosen to get a large enough signal from the ATP but small enough to not lose light from attenuation. The weighted centreline PO2 and SO2 drop are shown in Fig 14.
The ideal device was simulated with channel height of 0.5 mm and width of 0.3 mm, a 0.02 mm spin coat and a 1 mm long exchange window. This figure shows the weighted centreline drop in PO2 (blue) and the weighted centreline SO2 (red) as a function of position along the RBC channel. The black dashed line indicates the location of the exchange window.
Microfluidic devices have become increasingly popular for use in biological studies due to their reduced sample consumption, relative low costs and length scales that are comparable to dimensions on the cellular level. Microfluidic devices are used in a wide range of biological applications including hemodynamics at the microvascular scale [32–34] and cell behaviour under shear stress [23, 35, 36]. Microfluidic devices can be used to establish gradients of small molecules [37–40]. Further, in recent years, microfluidic devices have been used to create micro-scale cell cultures that mimic in vivo micro-environments to study physiological tissue interactions [41–44]. Due to their vast applications in biological settings, microfluidic devices must be designed to meet the oxygen requirements of the study. Living cells are highly sensitive to the oxygen levels in their environment and may behave irregularly when exposed to unphysiological levels [45–47]. And since the results of our study demonstrate the crucial role that geometry can play in oxygen transport, it is an important consideration for the design of microfluidic channels. Our methods can also be applied to other gases and solutes as well as temperature.
Various studies have implemented mathematical models in order to validate and optimize microfluidic designs [13–15, 17, 18]. In these studies, the use of mathematical modelling was necessary for ensuring the proper distribution of oxygen in their application. Some of these studies considered only 2D models of their devices [13–15], while others used 3D models [17, 18]. In the studies that employed 2D models, 2D geometry was often sufficient to approximate the overall transport due to inherent symmetries in the device. In our application, a 3D geometry was crucial for two reasons. First, our device possessed two stream-wise directions (gas flow direction and RBC flow direction). Further a 2D model would not allow us to vary parameters that lied orthogonal to the plane that was being modelled.
In conclusion, although the 1D model provided important qualitative insights, the 3D model demonstrated that diffusion through the PDMS surrounding the RBC channel yielded unexpected relationships important to the design of the device. Thus the use of a 3D transport model is crucial for guiding our optimal design.
- Conceptualization: RJS GMF DG CGE.
- Formal analysis: RJS.
- Methodology: RJS.
- Software: RJS.
- Writing – original draft: RJS GMF DG CGE.
- Writing – review & editing: RJS GMF DG CGE.
- 1. Ellsworth ML, Forrester T, Ellis CG, Dietrich HH. The erythrocyte as a regulator of vascular tone. American Journal of Physiology-Heart and Circulatory Physiology. 1995;269(6):H2155–H2161. pmid:8594927
- 2. Fischer DJ, Torrence NJ, Sprung RJ, Spence DM. Determination of erythrocyte deformability and its correlation to cellular ATP release using microbore tubing with diameters that approximate resistance vessels in vivo. Analyst. 2003;128(9):1163–1168. pmid:14529024
- 3. Bergfeld G, Forrester T. Release of ATP from human erythrocytes in response to a brief period of hypoxia and hypercapnia. Cardiovascular Research. 1992;26(1):40–47. pmid:1325292
- 4. Light DB, Capes TL, Gronau RT, Adler MR. Extracellular ATP stimulates volume decrease in Necturus red blood cells. American Journal of Physiology-Cell Physiology. 1999;277(3):C480–C491. pmid:10484335
- 5. Jagger JE, Bateman RM, Ellsworth ML, Ellis CG. Role of erythrocyte in regulating local O2 delivery mediated by hemoglobin oxygenation. American Journal of Physiology-Heart and Circulatory Physiology. 2001;280(6):H2833–H2839. pmid:11356642
- 6. Dietrich HH, Kajita Y, Dacey R. Local and conducted vasomotor responses in isolated rat cerebral arterioles. American Journal of Physiology-Heart and Circulatory Physiology. 1996;271(3):H1109–H1116. pmid:8853348
- 7. Ellsworth ML, Ellis CG, Goldman D, Stephenson AH, Dietrich HH, Sprague RS. Erythrocytes: oxygen sensors and modulators of vascular tone. Physiology. 2009;24(2):107–116. pmid:19364913
- 8. Ellis CG, Milkovich S, Goldman D. What is the efficiency of ATP signaling from erythrocytes to regulate distribution of O2 supply within the microvasculature? Microcirculation. 2012;19(5):440–450. pmid:22587367
- 9. Bateman RM, Sharpe MD, Jagger JE, Ellis CG. Sepsis impairs microvascular autoregulation and delays capillary response within hypoxic capillaries. Critical Care. 2015;19(1):1–14. pmid:26537126
- 10. Ellis CG, Goldman D, Hanson M, Stephenson AH, Milkovich S, Benlamri A, et al. Defects in oxygen supply to skeletal muscle of prediabetic ZDF rats. American Journal of Physiology-Heart and Circulatory Physiology. 2010;298(6):H1661–H1670. pmid:20207810
- 11. Sprague RS, Stephenson AH, Bowles EA, Stumpf MS, Lonigro AJ. Reduced expression of Gi in erythrocytes of humans with type 2 diabetes is associated with impairment of both cAMP generation and ATP release. Diabetes. 2006;55(12):3588–3593. pmid:17130508
- 12. Li C, Chaung W, Mozayan C, Chabra R, Wang P, Narayan RK. A New Approach for On-Demand Generation of Various Oxygen Tensions for In Vitro Hypoxia Models. PloS one. 2016;11(5):e0155921. pmid:27219067
- 13. Zahorodny-Burke M, Nearingburg B, Elias AL. Finite element analysis of oxygen transport in microfluidic cell culture devices with varying channel architectures, perfusion rates, and materials. Chemical Engineering Science. 2011;66(23):6244–6253.
- 14. Kim MC, Lam RHW, Thorsen T, Asada HH. Mathematical analysis of oxygen transfer through polydimethylsiloxane membrane between double layers of cell culture channel and gas chamber in microfluidic oxygenator. Microfluidics and Nanofluidics. 2013;15(3):285–296.
- 15. Kang TY, Hong JM, Jung JW, Yoo JJ, Cho DW. Design and Assessment of a Microfluidic Network System for Oxygen Transport in Engineered Tissue. Langmuir. 2013;29(2):701–709. pmid:23234496
- 16. Oppegard SC, Eddington DT. A microfabricated platform for establishing oxygen gradients in 3-D constructs. Biomedical Microdevices. 2013;15(3):407–414. pmid:23344840
- 17. Wang L, Liu W, Wang Y, Wang Jc, Tu Q, Liu R, et al. Construction of oxygen and chemical concentration gradients in a single microfluidic device for studying tumor cell–drug interactions in a dynamic hypoxia microenvironment. Lab on a Chip. 2013;13(4):695–705. pmid:23254684
- 18. Chen YA, King AD, Shih HC, Peng CC, Wu CY, Liao WH, et al. Generation of oxygen gradients in microfluidic devices for cell culture using spatially confined chemical reactions. Lab on a Chip. 2011;11(21):3626–3633. pmid:21915399
- 19. Abaci HE, Devendra R, Soman R, Drazer G, Gerecht S. Microbioreactors to manipulate oxygen tension and shear stress in the microenvironment of vascular stem and progenitor cells. Biotechnology and Applied Biochemistry. 2012;59(2):97–105. pmid:23586790
- 20. Ghonaim NW, Lau LW, Goldman D, Ellis CG, Yang J. A Micro-Delivery Approach for Studying Microvascular Responses to Localized Oxygen Delivery. Microcirculation. 2011;18(8):646–654. pmid:21914035
- 21. Ghonaim NW, Fraser GM, Ellis CG, Yang J, Goldman D. Modeling steady state SO2-dependent changes in capillary ATP concentration using novel O2 micro-delivery methods. Frontiers in Physiology. 2013;4. pmid:24069001
- 22. Sove RJ, Ghonaim N, Goldman D, Ellis CG. A Computational Model of a Microfluidic Device to Measure the Dynamics of Oxygen-Dependent ATP Release from Erythrocytes. Plos One. 2013;. pmid:24312316
- 23. Wan J, Ristenpart WD, Stone HA. Dynamics of shear-induced ATP release from red blood cells. Proceedings of the National Academy of Sciences. 2008;105(43):16432–16437. pmid:18922780
- 24. Geuzaine C, Remacle JF. Gmsh: A 3-D finite element mesh generator with built-in pre-and post-processing facilities. International Journal for Numerical Methods in Engineering. 2009;79(11):1309–1331.
- 25. Weller HG, Tabor G, Jasak H, Fureby C. A tensorial approach to computational continuum mechanics using object-oriented techniques. Computers in Physics. 1998;12(6):620–631.
- 26. Patankar SV, Spalding DB. A calculation procedure for heat, mass and momentum transfer in three-dimensional parabolic flows. International Journal of Heat and Mass Transfer. 1972;15(10):1787–1806.
- 27. Hellums JD, Nair PK, Huang NS, Ohshima N. Simulation of intraluminal gas transport processes in the microcirculation. Annals of Biomedical Engineering. 1995;24(1):1–24. pmid:8669708
- 28. Hill AV. The possible effects of the aggregation of the molecules of haemoglobin on its dissociation curves. J Physiol (Lond). 1910;40:4–7. pmid:22844429
- 29. Reddy JN, Gartling DK. The finite element method in heat transfer and fluid dynamics. CRC press; 2010.
- 30. Saad Y, Schultz MH. GMRES: A generalized minimal residual algorithm for solving nonsymmetric linear systems. SIAM Journal on Scientific and Statistical Computing. 1986;7(3):856–869.
- 31. Dietrich HH, Ellsworth ML, Sprague RS, Dacey RG. Red blood cell regulation of microvascular tone through adenosine triphosphate. American Journal of Physiology-Heart and Circulatory Physiology. 2000;278(4):H1294–H1298. pmid:10749727
- 32. Cokelet G, Soave R, Pugh G, Rathbun L. Fabrication of in vitro microvascular blood flow systems by photolithography. Microvascular Research. 1993;46(3):394–400. pmid:8121322
- 33. Shevkoplyas SS, Gifford SC, Yoshida T, Bitensky MW. Prototype of an in vitro model of the microcirculation. Microvascular Research. 2003;65(2):132–136. pmid:12686171
- 34. Quinn DJ, Pivkin I, Wong SY, Chiam KH, Dao M, Karniadakis GE, et al. Combined simulation and experimental study of large deformation of red blood cells in microfluidic systems. Annals of Biomedical Engineering. 2011;39(3):1041–1050. pmid:21240637
- 35. Price AK, Fischer DJ, Martin RS, Spence DM. Deformation-induced release of ATP from erythrocytes in a poly (dimethylsiloxane)-based microchip with channels that mimic resistance vessels. Analytical Chemistry. 2004;76(16):4849–4855. pmid:15307797
- 36. Moehlenbrock MJ, Price AK, Martin RS. Use of microchip-based hydrodynamic focusing to measure the deformation-induced release of ATP from erythrocytes. Analyst. 2006;131(8):930–937. pmid:17028727
- 37. Jiang X, Xu Q, Dertinger SK, Stroock AD, Fu Tm, Whitesides GM. A general method for patterning gradients of biomolecules on surfaces using microfluidic networks. Analytical Chemistry. 2005;77(8):2338–2347. pmid:15828766
- 38. Dertinger SK, Chiu DT, Jeon NL, Whitesides GM. Generation of gradients having complex shapes using microfluidic networks. Analytical Chemistry. 2001;73(6):1240–1246.
- 39. Abhyankar VV, Lokuta MA, Huttenlocher A, Beebe DJ. Characterization of a membrane-based gradient generator for use in cell-signaling studies. Lab on a Chip. 2006;6(3):389–393. pmid:16511622
- 40. Wu H, Huang B, Zare RN. Generation of complex, static solution gradients in microfluidic channels. Journal of the American Chemical Society. 2006;128(13):4194–4195. pmid:16568971
- 41. Inamdar NK, Borenstein JT. Microfluidic cell culture models for tissue engineering. Current Opinion in Biotechnology. 2011;22(5):681–689. pmid:21723720
- 42. Huh D, Hamilton GA, Ingber DE. From 3D cell culture to organs-on-chips. Trends in Cell Biology. 2011;21(12):745–754. pmid:22033488
- 43. El-Ali J, Sorger PK, Jensen KF. Cells on chips. Nature. 2006;442(7101):403–411. pmid:16871208
- 44. Ghaemmaghami AM, Hancock MJ, Harrington H, Kaji H, Khademhosseini A. Biomimetic tissues on a chip for drug discovery. Drug Discovery Today. 2012;17(3):173–181. pmid:22094245
- 45. Jornot L, Mirault M, Junod A. Protein synthesis in hyperoxic endothelial cells: evidence for translational defect. Journal of Applied Physiology. 1987;63(2):457–464. pmid:2443475
- 46. Sanders SP, Zweier JL, Kuppusamy P, Harrison SJ, Bassett D, Gabrielson EW, et al. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. Journal of Clinical Investigation. 1993;91(1):46. pmid:8380815
- 47. Bjerkvig R, Thorsen J, Svendsen E, Holmsen H, Thorsen T. Effects of hyperoxia on human endothelial cell proliferation and morphology in vitro. Undersea Biomedical Research. 1992;19(6):415–426. pmid:1304669